Loading clinical trials...
Loading clinical trials...
Positive Impact of Endovascular Options for Treating Aneurysms Early (PIVOTAL)
The purpose of this study is to compare endovascular repair using any FDA approved Medtronic AAA Stent Graft System versus surveillance in subjects with smaller abdominal aortic aneurysms (AAA)(4-5CM), with respect to AAA rupture and AAA related deaths.
Age
40 - 90 years
Sex
ALL
Healthy Volunteers
No
University of Alabama
Birmingham, Alabama, United States
Tucson Vascular Surgery
Tucson, Arizona, United States
University of Arizona - UMC
Tucson, Arizona, United States
VA Hospital
Little Rock, Arkansas, United States
Palomar Hospital
Escondido, California, United States
Long Beach VA Healthcare System
Long Beach, California, United States
UCLA Medical Center
Los Angeles, California, United States
University of Southern California
Los Angeles, California, United States
Stanford University VA
Palo Alto, California, United States
UC Davis Medical Center
Sacramento, California, United States
Start Date
March 1, 2005
Primary Completion Date
January 1, 2010
Completion Date
January 1, 2010
Last Updated
October 11, 2021
728
ACTUAL participants
AneuRx AAA stent graft / Talent AAA stent graft
DEVICE
Lead Sponsor
Medtronic Cardiovascular
Collaborators
NCT07184723
NCT06710938
NCT06884397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions